companies

Vinehealth Seed

Founded 2018
Employees 20+
Primary contact
124 City Road
EC1V 2NX London
United Kingdom
Links
https://www.vinehealth.ai/
Diseases & Conditions
Sections
🏦 Potential exit path: M&A
Founded in 2018, Vinehealth has built an app applying behavioral science and AI to deliver highly personalized support for cancer patients at scale. The platform also acts as a channel through which patients can be remotely monitored by their clinicians as they provide feedback on symptoms and report any treatment side effects. On the other hand, the technology makes it easier to gather patient-reported outcome (PRO) data to inform health service delivery, drug development and research. The company has been financially supported by the UK's National Health Service (NHS).
Select partners: The Royal Marsden NHS Foundation Trust, The National Hospital of Neurology and Neurosurgery, Health Foundation.
Founded 2018
Employees 20+
Primary contact
124 City Road
EC1V 2NX London
United Kingdom
Links
https://www.vinehealth.ai/
Diseases & Conditions
Sections

Funding 💰

Total $8.5M
Last round 🔗 $5.5M
December 3, 2021.
Select investors Talis Capital, Playfair Capital, Ascension Health System, KHP MedTech Innovations, VOYAGERS Health-Tech Fund

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Solving a real problem: Vinehealth wants to solve a real problem and make it easier for cancer patients to better manage their disease from home through a complex healthcare system.
  • The industry believes in Vinehealth: In addition to traditional VCs, the company also got backing from other healthcare players, which obviously think Vinehealth is onto something. These include Faisal Mehmud, VP and former medical director of Bristol Myers Squibb; and KHP MedTech Innovations, a collaboration between King's College London, King's College Hospital NHS Foundation Trust and Guy's and St Thomas' NHS Trust.
  • Eye on the US market: Vinehealth is gearing up to expand in the U.S. market. That was one of the main ideas behind its Seed financing round. 🔗
  • TechCrunch's startup to watch: The tech publication caught Vinehealth in March 2019 during Entrepreneur First's 11th Demo Day in London. At that time, it noted that co-founders are "rather well qualified" and that the company has a "great advisory board." 🔗

Video ▶️

Awards & Recognitions 🏆

  • 2021 Europas: Hottest HealthTech Startup Winner 🔗
  • 2021 Great British Entrepreneur Awards: Among 15 Health and Fitness Entrepreneurs to Watch 🔗
  • 2020 DigitalAgenda's Impact Awards for Health 🔗

Quotes 💬

“
We'd been keeping a close eye on Vinehealth's growth for several months before we invested in the company, given its unique value proposition where healthcare outcomes work in direct correlation with financial outcomes. It's a win-win-win for patients, hospitals and pharmaceutical companies, which is rarely the case in the healthcare space where parties are often at odds with one another.
— Beatrice Aliprandi, principal at Talis Capital
Last update: August 16, 2022